Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-14

Clinical Trial Update: Efficacy of Metformin for Sputum Conversion in Patients With Active Pulmonary Tuberculosis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update evaluates the efficacy of metformin for sputum conversion in patients with active pulmonary tuberculosis (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Mahidol University | Conditions: Tuberculosis, Pulmonary | Phase 1, Phase 2 | Status: UNKNOWN